SCI & TECH● LOW22h ago · Sep 1, 2026, 6:33 AM
GSK to advance mRNA seasonal flu vaccine to phase 3 trial
Seeking Alpha Tech · global
GSK is progressing its mRNA seasonal flu vaccine to a phase 3 clinical trial. This move marks a significant step in the development of new vaccine technology.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH48m agoBlanket bans on AI could cause data centre panic irrigator.com.au · AustraliaSCI & TECH1h ago‘Paradox of progress’: What it will take to turn renewables boom into a real drop in emissionsEuroNews [en]SCI & TECH1h agoMediterranean in flux: four decades of data reveal climate change impactEuroNews [en]SCI & TECH1h agoChina’s 2026 moon laser communication speed is slower than Nasa’s in 2013South China Morning Post